samd
(3)
Huma
Huma is a London-based digital health technology company that builds a regulated, modular software platform used by hospitals, pharmaceutical companies and governments to run remote patient monitoring, 'hospital at home', companion apps and decentralized clinical trials. Founded in 2011 as Medopad and rebranded to Huma in 2020, it combines predictive algorithms, digital biomarkers and real-world data with a no-code Huma Cloud Platform so partners can launch regulated, disease- and device-agnostic health apps. Its Software as a Medical Device holds EU MDR Class IIb, US FDA Class II and UK MHRA registrations, and its technology has reached thousands of hospitals and tens of millions of patients worldwide.
Sware
Sware is a Boston-based software company that modernizes GxP validation for life sciences. Its cloud-native Res_Q platform and developer-focused GxPNext product use AI and a decade of regulated validation knowledge to automate the computer system validation (CSV) work that the FDA and other regulators require - helping pharmaceutical, biotech, medical device and CDMO teams cut validation time and cost while staying audit-ready. Formerly Boston Technology Research (BTR), the company rebranded to Sware in 2022 and has raised roughly $26-27M to date.
Wonder Sciences
Wonder Sciences is a Los Angeles-based mental health and research company reengineering psychiatric care through psychedelic medicine, clinical research, and AI. Best known for its consumer brand Wondermed - an at-home, low-dose ketamine-assisted telehealth protocol for anxiety and depression - the company is building an AI-native clinical operating system that fuses medication, therapy, and behavioral data into actionable insights. Founded by Ryan Magnussen in 2022, it raised roughly $4.6M-$5.6M in seed funding from investors including Aubrey Marcus and James Foster.